VSTM FY 2015 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$376M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$754,000

Operating Income

-$58M

Net Income

-$58M

EPS (Diluted)

$-19.32

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$113M

Total Liabilities

$11M

Stockholders' Equity

$102M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$754,000	$0	—
Operating Income	-$58M	-$54M	-8.6%
Net Income	-$58M	-$53M	-8.4%